Labcorp Holdings Inc. (LON:0JSY)

Market Cap	16.13B
Revenue (ttm)	10.20B
Net Income (ttm)	565.63M
Shares Out	n/a
EPS (ttm)	6.71
PE Ratio	28.51
Forward PE	16.31
Dividend	2.23 (0.85%)
Ex-Dividend Date	May 29, 2025

Volume	302
Average Volume	816
Open	262.53
Previous Close	262.86
Day's Range	261.95 - 262.53
52-Week Range	198.52 - 263.45
Beta	0.79
RSI	63.58
Earnings Date	Jul 31, 2025

About Labcorp Holdings

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1995
• Employees: 70,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0JSY

Financial Performance

In 2024, Labcorp Holdings's revenue was $13.01 billion, an increase of 6.97% compared to the previous year's $12.16 billion. Earnings were $746.00 million, an increase of 78.47%.

Financial numbers in USD